D. E. McFarlin - Concepedia

Author

D. E. McFarlin

National Institute of Neurological Disorders and Stroke

Also Known As

D E McFarlin, D. E. MCFARLIN, D. E. McFARLIN, D. E. McFarlin, D. E. Mcfarlin, D. McFarlin, D.E. McFARLIN, D.E. McFarlin, Dale E. McFarlin, DaleE. McFarlin

Publications

6.1K

Citations

H-Index

112

Concepts

All Affiliations

National Institute of Neurological Disorders and Stroke National Institutes of Health Albert Einstein College of Medicine Georgetown University Georgetown University Medical Center

About

D. E. McFarlin is an author at National Institute of Neurological Disorders and Stroke specializing in medicine, immunology, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	49	3.8K
2	Allergy	17	18	1.8K
3	Health Sciences	3	3	296
4	Engineering	1	1	70
5	Social Sciences	1	1	131

D. E. McFarlin

Publications

5.9K

Citations

H-Index

Page 1

	Year	Citations
Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after <i>in vitro</i> activation of lymph node cells by myelin basic protein: requirement for Lyt 1+ 2- T lymphocytes. C B Pettinelli, D. E. McFarlin The Journal of Immunology	1981	587
Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1 Michael K. Racke, Suhayl Dhib‐Jalbut, B. Cannella, The Journal of Immunology	1991	379
Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. Dolores Jaraquemada, M Flerlage, J R Richert, The Journal of Immunology Neurological DisorderImmunodeficienciesT-regulatory CellImmunologyImmune Regulation	1990	342
Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice Foroozan Mokhtarian, D. E. McFarlin, Cedric S. Raine Nature NeuroregenerationAutoimmune DiseaseMedicineT-regulatory CellImmunology	1984	309
A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis. Mark D. Howell, Dolores Jaraquemada, M Flerlage, The Journal of Experimental Medicine Cytotoxic T CellsImmunologyImmune RegulationImmunodominanceAntigen Processing	1991	286
Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. Michael K. Racke, Deborah L. Burnett, S H Pak, The Journal of Immunology Allergy MedicineT-regulatory CellImmunologyImmune RegulationImmunologic Mechanism	1995	250
Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine–enhancing magnetic resonance imaging lesions Mary E. Smith, Lael A. Stone, Paul S. Albert, Annals of Neurology Neurological DisorderClinical NeurologyNeurological ProgressBrain LesionMagnetic Resonance Imaging	1993	242
Chronologic neuropathology of relapsing experimental allergic encephalomyelitis in the mouse. Alan S. Brown, D. E. McFarlin, Cedric S. Raine PubMed	1982	167
Transthyretin Pro55, a variant associated with early-onset, aggressive, diffuse amyloidosis with cardiac and neurologic involvement D R Jacobson, D. E. McFarlin, Immaculata Kane, Human Genetics Alzheimer's DiseaseTransthyretin Pro55PathologyNeurochemical BiomarkersProtein Misfolding	1992	155
Neuropathology of experimental allergic encephalomyelitis in inbred strains of mice. Cedric S. Raine, L. B. Barnett, A. M. Brown, PubMed	1980	154

Page 1